Moreover, immunoblotting showed increased expression of the mesenchymal marker N-cadherin and decreased expression of claudin-1, a critical component of tight junctions and an epithelial marker, in UM-UC-5 cells treated with supernatants of tumour cell-platelet reactants (Fig. 1e). This evidence concerns the gene CLDN1 and neoplasm.